Turn Therapeutics Inc.
Turn Therapeutics Inc. scores highest on Nitro (71) and lowest on Price (0). Its PosiPenta is 39.98 out of 100, weaker than most similar companies.
On the Penta Grid this week, Turn Therapeutics Inc. is Grid #541 of 837 in the Healthcare sector in United States, and Grid #2,889 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Turn Therapeutics Inc. | 39.98 | 0 | 61 | 71 | 4 | 64 |
| Benitec Biopharma Inc. | 42.20 | 32 | 25 | 28 | 69 | 56 |
| Arcturus Therapeutics Holdings Inc. | 37.40 | 31 | 20 | 47 | 49 | 40 |
| Artiva Biotherapeutics, Inc. | 44.03 | 41 | 29 | 45 | 61 | 44 |
| Surrozen, Inc. | 50.18 | 0 | 38 | 66 | 92 | 55 |
| Contineum Therapeutics, Inc. | 39.09 | 38 | 27 | 27 | 63 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -36.45 |
| P/B ratio | 467.31 |
EEarnings
| Trailing EPS | ₹-27.47 |
| Forward EPS | ₹-14.21 |
NNitro
| Price | 1001.14 |
| 52-week high | 1558.06 |
| 52-week low | 243.42 |
| Fall from 52-week high | 35.7% |
TTorque
| Return on equity (ROE) | -686.28% |
| Debt-to-equity | 8.91 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹3,040 Cr |
| Insider holding | 53.88% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Turn Therapeutics Inc.'s PosiPenta score?
Turn Therapeutics Inc.'s PosiPenta is 39.98 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Turn Therapeutics Inc. stand on the Penta Grid?
On the Penta Grid this week, Turn Therapeutics Inc. is Grid #541 of 837 in the Healthcare sector in United States, and Grid #2,889 of 4,000 in United States.
Which PosiPenta pillar is strongest for Turn Therapeutics Inc.?
Nitro (momentum), with a score of 71 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Turn Therapeutics Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Turn Therapeutics Inc.'s PosiPenta changed since last week?
Yes, it rose 2.28 points, from 37.70 to 39.98.
PositoAI is for research and education only and is not investment advice.